Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C-Reference-Cited by-同舟云学术

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C

Published:2019-12 Issue:6 Volume:71 Page:1099-1105
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Childs Kate,Davis Christopher,Cannon Mary,Montague Sarah^ORCID,Filipe Ana,Tong Lily^ORCID,Simmonds Peter^ORCID,Smith Donald,Thomson Emma C.,Dusheiko Geoff,Agarwal Kosh

Funder

Wellcome Trust

Medical Research Council

Publisher

Elsevier BV

Subject

Hepatology

Reference21 articles.

1. Global hepatitis report;Hutin,2017

2. New highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments;Davis;Hepatology,2018

3. Hepatitis C and the absence of genomic data in low-income countries: a barrier on the road to elimination?;Niebel;Lancet Gastroenterol Hepatol,2017

4. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014

5. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: prevalence and effect on treatment outcome;Zeuzem;J Hepatol,2017

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study;The Lancet Microbe;2024-07

2. Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation;Value in Health;2024-07

3. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

4. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis;Swiss Medical Weekly;2024-06-24

5. ‘Unusual’ HCV genotype subtypes: origin, distribution, sensitivity to direct-acting antiviral drugs and behaviour on antiviral treatment and retreatment;Gut;2024-05-23